Arama

EISSN 2148-5607

TJG IS INDEXED IN WEB OF SCIENCE AND PUBMED IMPACT FACTOR: 1.2

Turkish Journal of Gastroenterology

35 407 2024

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Search

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 7 results

Ranking

Release Date Sort Sort Article Type

Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis

Gökhan KABAÇAM, George N. DALEKOS, Yılmaz ÇAKALOĞLU , Kalliopi ZACHOU, Thomas BOCK, Andreas ERHARDT, Stefan ZEUZEM, Fehmi TABAK, Kendal YALÇIN , A. Mithat Bozdayı, Hans P. DIENES, Hakan BOZKAYA, Michael MANNS, Heiner WEDEMEYER, Cihan Yurdaydın

(Turk J Gastroenterol 2012; 23: 560-568) DOI: 10.4318/tjg.2012.0538

Abstract Full Text ( PDF) Related Articles

The efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in chronic hepatitis C patients

Necati YENİCE, Özgür MEHTAP, Mübeccel GÜMRAH, Nurten ARICAN

(Turk J Gastroenterol 2006; 17: 94-98)

Abstract Full Text ( PDF) Related Articles

Neutropenia and viral load decline during treatment of hepatitis C virus genotype-4

Aliaa Amer, Fatma Shebl, Moutaz Derbala

(Turk J Gastroenterol 2014; 25: 15-19) DOI: 10.5152/tjg.2014.4443

Abstract Full Text ( PDF) Related Articles